• Home
    • Clinical Curriculum
    • Didactic Curriculum
    • Sub-Specialties
    • Diversity and Inclusion
    • Residency Awards
    • Wellness
    • Cook County ED
    • Benefits
    • Interview Day Logistics
    • About Chicago
    • FAQ
    • Contact Information
    • Medical Student Elective
    • Rotating Student Resources
    • Diversity Externship Scholarship
    • Ultrasound
    • Simulation
    • Toxicology
    • Residents
    • Fellows
    • Faculty
    • Program Directors
    • Where We're From
    • Where Are We Going?
    • Alumni
  • Blog
Menu

Cook County Emergency Medicine Residency

  • Home
  • Residency
    • Clinical Curriculum
    • Didactic Curriculum
    • Sub-Specialties
    • Diversity and Inclusion
    • Residency Awards
    • Wellness
  • Recruitment
    • Cook County ED
    • Benefits
    • Interview Day Logistics
    • About Chicago
    • FAQ
    • Contact Information
  • Students
    • Medical Student Elective
    • Rotating Student Resources
    • Diversity Externship Scholarship
  • Fellowships
    • Ultrasound
    • Simulation
    • Toxicology
  • People
    • Residents
    • Fellows
    • Faculty
    • Program Directors
    • Where We're From
    • Where Are We Going?
    • Alumni
  • Blog

the County Consult

A Cook County Hospital Emergency Medicine Blog for up-to-date medicine and more.

Pharm.jpeg

PharmD Pearls: PPI in GI Bleeds - What's Your Route?

August 5, 2021

Clinical Conundrum: Is there a difference in efficacy between PO and IV Proton Pump Inhibitors (PPIs) in the management of GI bleeds? 

Background:

  • Upper gastrointestinal bleeds (UGIB) are caused by damage along the mucosal lining and the presence of gastric acid and pepsin.

  • Proton pump inhibitors (PPI) irreversibly inhibit proton pumps to decrease gastric acid secretion and increase intestinal pH.

  • Increasing intestinal pH > 6 inactivates pepsin and promotes mucosal protection.  

Answer:

  • The current standard of care for UGIB treatment is IV PPI either as a continuous infusion or intermittent bolus dosing; however, ORAL PPI use has also been shown to be effective.

  • IV PPI regimens have shown faster onset of action in increasing the pH of the stomach with IV doses achieving a pH > 6 in 2 to 3 hours versus 3 to 4 hours with oral dosing.

  • Nevertheless, studies have shown no difference between IV versus oral PPI regimens in UGIB with regards to mortality, rebleeding rates, need for surgical intervention, blood transfusions, and duration of hospital stay.

  • Therefore, you can consider ORAL PPI use unless the following limitations exist for ORAL PPI's: restrictions on oral intake,  critically ill patients where altered GI absorption is a concern, hemodynamically unstable, massive active GIB.  

Reference:

  • Laine L, Jensen DM. ACG Practice Guidelines: Management of Patients with Ulcer Bleeding. Am J Gastroenterol. 2012; 107: 345 – 360.

  • Worden JC, Hanna KS. Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding. Am J Health-Syst Pharm. 2017; 74: 109 – 116.

  • Tringali A, Manta R, Sica M, et al. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis. Br J Clin Pharmacol. 2017; 83(8): 1619 – 1635.

Written by:

Paula Krzos, Doctor of Pharmacy Candidate, Class of 2021

Reviewed by:

Joanne C. Routsolias, PharmD, RN, BCPS

Clinical PharmD Specialist - Emergency Medicine/Toxicology

Cook County Health

 


In Pharmacology Tags PharmD Pearl
← The Toxic Shelf: Mad Honey PoisoningOrtho Pearls: Galeazzi Fracture →
  • Abdomen/GI
  • Cardiology
  • Critical Care
  • HEENT
  • Infectious Disease
  • Neurology
  • OB/GYN
  • Orthopedics/MSK
  • Pediatrics
  • Pharmacology
  • Psychiatry
  • Pulmonary
  • Renal
  • Sim Corner
  • Social EM
  • Toxicology
  • Trauma
  • Ultrasound
Tweets by @CookCountyEM

Contact Information

© 2020 Cook County Emergency Medicine